WAYNE, Pa.--(BUSINESS WIRE)--Oct. 29, 2018--
NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX)
focused on addressing unmet needs in the field of urology, today
announced the company received the Phoenix 2018 Emerging Growth Company
Award at the 25th Annual Phoenix Medical Device and
Diagnostic Conference in Laguna Beach, Calif. sponsored by the firm
Wilson Sonsini Goodrich & Rosati.
The Emerging Growth Company award is presented to an organization that
has undergone a strategically significant merger, a highly successful
IPO, dramatic growth in sales, or the creation of a major new product or
service. Last year, NeoTract was acquired by Teleflex Incorporated in a
transaction valued at up to $1.1 billion.
“We are thrilled to be recognized with the Emerging Growth Award by the
respected Phoenix conference organizers and our medtech community,” said
Dave Amerson, president of the Teleflex Interventional Urology business
unit. “I am pleased to share this award with every member of the
NeoTract team. Although we are proud of our achievement as a business,
we are even prouder that we’re succeeding in our mission to improve the
lives of men around the world with benign prostatic hyperplasia (BPH).”
NeoTract’s FDA-cleared UroLift® System is a proven, minimally
invasive technology for treating lower urinary tract symptoms due to
BPH. The UroLift permanent implants, delivered during a minimally
invasive transurethral outpatient procedure, relieve prostate
obstruction and open the urethra directly without cutting, heating, or
removing prostate tissue. The UroLift System Prostatic Urethral Lift
procedure is recommended for the treatment of BPH in both the American
Urological Association and European Association of Urology clinical
guidelines.
The Phoenix Awards recognize outstanding achievements in the medical
device and diagnostic industry to individuals and companies selected by
industry CEOs. NeoTract received the Phoenix Most Promising New Product
Award in 2016.
About Wilson Sonsini Goodrich & Rosati
For more than 50 years, Wilson Sonsini Goodrich & Rosati has offered a
broad range of services and legal disciplines focused on serving the
principal challenges faced by the management and boards of directors of
business enterprises. The firm is nationally recognized as a leader in
the fields of corporate governance and finance, mergers and
acquisitions, private equity, securities litigation, employment law,
intellectual property, and antitrust, among many other areas of law.
With deep roots in Silicon Valley, Wilson Sonsini Goodrich & Rosati has
offices in Austin; Beijing; Boston; Brussels; Hong Kong; London; Los
Angeles; New York; Palo Alto; San Diego; San Francisco; Seattle;
Shanghai; Washington, D.C.; and Wilmington, DE. For more information,
visit www.wsgr.com.
About NeoTract | Teleflex Interventional Urology
A wholly owned subsidiary of Teleflex Incorporated, the Teleflex
Interventional Urology Business Unit is dedicated to developing
innovative, minimally invasive and clinically effective devices that
address unmet needs in the field of urology. Our initial focus is on
improving the standard of care for patients with BPH using the UroLift
System, a minimally invasive permanent implant system that treats
symptoms while preserving normal sexual function. Learn more at www.NeoTract.com.
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed to
improve the health and quality of people’s lives. We apply purpose
driven innovation – a relentless pursuit of identifying unmet clinical
needs – to benefit patients and healthcare providers. Our portfolio is
diverse, with solutions in the fields of vascular and interventional
access, surgical, anesthesia, cardiac care, urology, emergency medicine
and respiratory care. Teleflex employees worldwide are united in the
understanding that what we do every day makes a difference. For more
information, please visit www.teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®,
Rusch®, UroLift® and Weck® – trusted brands united by a common sense of
purpose.
MA00323-01 Rev A
View source version on businesswire.com: https://www.businesswire.com/news/home/20181029005041/en/
Source: Teleflex Incorporated
For Teleflex Incorporated:
Jake Elguicze, 610-948-2836
Treasurer
and Vice President, Investor Relations
or
Media:
Nicole
Osmer, 650-454-0504
nicole@healthandcommerce.com